Zymo Research granted CE IVD Mark for sample collection devices


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Zymo Research granted CE IVD Mark for sample collection devices
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield reagent and collection devices.

Zymo Research announced that three of its DNA/RNA Shield collection devices: 1) DNA/RNA Shield collection tube w/ swab, 2) DNA/RNA Shield Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield Fecal Collection Tube are now CE IVD marked for in vitro diagnostic (IVD) applications.

The DNA/RNA Shield product line includes sample collection, preservation, and transportation devices for medical specimens used in research and is now available for in vitro diagnostics (e.g., COVID-19 testing). To receive the CE IVD mark, scientists at Zymo Research collected extensive performance data on the sample (pathogen) inactivation and nucleic acid preservation. The results confirmed an unprecedented stabilization of the samples (weeks/months) and DNA (many years) when the samples were stored at ambient temperature. Since DNA/RNA Shield immediately inactivates pathogens, including SARS-CoV-2, the virus that causes COVID-19, sample transportation is much safer for laboratory professionals and frontline workers.

"We are standardizing sample collection in clinical and research settings," said Dr Stanislav Forman of Zymo Research Corp. "This technology provides a level of safety for first responders and service providers alike; while pathogens are inactivated, the nucleic acid signatures are maintained. The CE IVD mark allows us to support many more clinical labs and organizations globally, including those performing COVID-19 testing during the current pandemic."

The CE IVD mark comes at a critical time, as many labs and organizations need sample collection devices to support COVID-19 testing workflows. Zymo Research already supports large-scale COVID-19 global testing efforts with its DNA/RNA Shield product, including the Corona Testing Centre at the Stuttgart Airport. The test centre is operated by CeGaT GmbH, a provider of genetic diagnostics and NGS services, based in Tübingen, Germany. For the test, the DNA/RNA Shield collection tube w/ swab is being used to collect nasopharyngeal samples from airport passengers, who are screened for SARS-CoV-2 viral RNA using a real-time polymerase chain reaction (RT-PCR) test. Test results are available the next day as part of the state's efforts to contain the spread of COVID-19.

"We rely on Zymo Research sample collection tubes for acute SARS-CoV-2 diagnostics," said Dr Saskia Biskup, CEO Praxis für Humangenetik Tübingen & CeGaT GmbH. "We value the inactivating capabilities of the CE IVD-certified DNA/RNA Shield™ solution, which allows us safer sample handling and results in higher throughput in our lab."

Tags : #ZymoResearch #CEIVDMark #LatestPharmaNewsUpdateSep28 #SampleCollectionDevices #latestPharmaDeviceNewsUpdateSep28 #DrSaskiBiskup

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026